Last updated on March 2019

A Study to Assess the Safety Tolerability and Efficacy of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Brief description of study

This is a study to evaluate the long-term safety and tolerability of bimekizumab in adult subjects with moderate to severe chronic plaque psoriasis (PSO).

Clinical Study Identifier: NCT03598790

Find a site near you

Start Over

Ps0014 627

Itabashi-Ku, Japan
  Connect »

Ps0014 618

Shinjuku-Ku, Japan
  Connect »

Ps0014 607

Chiyoda-Ku, Japan
  Connect »

Ps0014 604

Minato-Ku, Japan
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.